Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Why Is Centene Corporation (CNC) Stock Up +5.00% Today?

Why Is Centene Corporation (CNC) Stock Up +5.00% Today?

Key Takeaways

  • CNC traded at $74.83, up $3.56 or 5.00%, from Friday's close of $71.27, with the session still open.
  • The primary catalyst was a federal decision to let states delay enforcement of Medicaid work requirements by six months, easing a looming eligibility risk for Centene's largest business line.
  • A secondary driver: Bernstein lifted its price target to $90 from $79 while keeping a Buy rating, the highest target among covering analysts.
  • Managed-care peers rallied in sympathy, with Molina Healthcare, Elevance Health, UnitedHealth, Humana and CVS all advancing, though gains were sorted by Medicaid exposure.
  • The move extends a policy-driven rally that began after the midterm elections, when policy-relief bets sent the stock up 12.6% in a single session.
  • News Significance Score: 40/100 — Moderate policy relief and a notable target hike, on a move about 2.6x the stock's typical daily swing.
  • Traders are watching which states opt into the transition period, ACA subsidy legislation, and fourth-quarter medical cost trends.
  • Investors can review Price Targets, Earnings and Forecast data on Tickeron's dedicated pages for a deeper view of the setup.
  • Explore Trending AI Robots to see which automated strategies currently rank highest across thousands of tickers.

Opening Summary

Centene Corporation (CNC) is a St. Louis-based managed care insurer that provides government-sponsored health coverage, chiefly Medicaid, Medicare prescription drug plans and individual marketplace plans, to roughly 20 million members and generates about $204 billion in annual revenue. Shares traded at $74.83 in Monday afternoon action, a gain of $3.56, or 5.00%, from Friday's closing level of $71.27. The direction is clearly higher, and the immediate cause is identifiable: Washington signaled it will give states more time before enforcing new Medicaid work requirements, while a prominent analyst raised its price objective to $90.

Medicaid Work-Requirement Delay Lifts the Group

The decisive news came from the Centers for Medicare & Medicaid Services, which told states they may adopt a six-month transition period before enforcing the work and community-engagement conditions written into the 2025 tax-and-spending law. Those rules were scheduled to take effect January 1, 2027. Under the transition option, states that elect it would not disenroll members who fail to meet the requirements during that window.

For Centene, the implications are direct. Medicaid produced about $29.6 billion of revenue in the September quarter, and the company ended the period with 11.9 million Medicaid members. A tighter eligibility regime would have removed members and pressured enrollment at the same moment the company is rebuilding margins. Pushing enforcement out reduces near-term attrition risk and buys management time, which is why the stock moved more than the broader sector.

The Bernstein Price Target Hike

Bernstein raised its target on CNC to $90 from $79 before the opening bell, retaining a Buy rating. That figure now sits above the roughly $75–$76 average target among the 21 analysts covering the company, and implies meaningful upside from Friday's close. Coming alongside the policy headline, it reinforced the view that consensus estimates may still understate the earnings recovery. The upgrade does not stand alone: Truist moved to $82 earlier in the month and J.P. Morgan lifted its target to $75, part of a steady wave of post-earnings revisions.

Sector Momentum, Not a Company-Specific Shock

Monday's tape was a sector event. Molina Healthcare (MOH), the most Medicaid-concentrated name in the group, gained more than 8%, while Elevance Health (ELV) rose nearly 4%. UnitedHealth (UNH), Humana (HUM) and CVS Health (CVS) all advanced by smaller amounts. The ordering follows exposure: the more a company's earnings depend on government programs, the larger the gain.

The move also extends a theme in place since the November 4 midterm results, when investors bet that a divided policy process would delay Medicaid funding cuts and restore enhanced marketplace subsidies. Centene jumped 12.6% that session and remains up more than 80% year to date.

Market Context and Trading Activity

Participation was firm but not exceptional. Roughly 4.6 million shares had changed hands by mid-afternoon against a 90-day average near 4.8 million, suggesting steady institutional interest rather than a volume spike. The stock gapped higher at the open, traded in a range of about $73.93 to $75.97, and held most of its gain.

Technically, the advance pushed shares back above the 50-day moving average near $67 and toward the 52-week high of $78.08 reached on November 5. The move was concentrated in Medicaid-exposed insurers rather than driven by broad index performance, and the gap between Molina's 8% and UnitedHealth's 1.4% shows investors were pricing policy sensitivity, not simply buying healthcare.

News Significance Score

The scale runs from 0, meaning no meaningful news and a routine price move, to 100, meaning transformative news and an extreme, rare move. This event scores 40 out of 100. The verified news was solid but not transformative: a timing delay in Medicaid eligibility rules plus a single analyst target increase, material for a company this levered to government programs but short of a change in law or a guidance reset. The price move was about 2.6 times the stock's average absolute daily change of roughly 1.9% over the past 60 sessions, and moves of 5% or more occurred only twice in that span. Moderate news and a moderately unusual move combine into a mid-range score.

What Comes Next for CNC

The fourth-quarter report is expected in early February 2027, and investors will focus on the health benefits ratio, which held at 92.7% in the third quarter, and on whether the company delivers on its raised 2026 adjusted earnings floor of above $5.20 per share. Guidance for 2027 will matter more, since membership headwinds are already known: marketplace enrollment has fallen to 3.40 million from 5.83 million a year earlier, California will move about 175,000 Health Net Medi-Cal members to fee-for-service on January 1, and Health Net is exiting the commercial group market.

The larger uncertainty is Medicare Advantage quality ratings. Roughly 60% of members sit in plans rated 3.5 stars or better for 2027 payments, but only about 42% clear that bar in the ratings that govern 2028, creating a bonus cliff. Legislative outcomes on ACA subsidies and state-level Medicaid expansion remain the swing factors for sentiment.

Trending AI Robots

Tickeron's Trending AI Robots page curates the automated strategies performing best under current market conditions from a library of hundreds of bots spanning thousands of tickers. Bots differ by strategy logic, holding period, performance metrics and the symbols they trade, so the featured lineup rotates as conditions shift. Reviewing the current leaders can help traders compare approaches and identify setups worth monitoring.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CNC

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CNC in upward trend: price rose above 50-day moving average on October 09, 2026

CNC moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 39 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CNC as a result. In 59 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The 10-day moving average for CNC crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +2.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNC advanced for three days, in 186 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 132 of 213 cases where CNC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.

Bearish Trend Analysis

The 10-day RSI Indicator for CNC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 19 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 60 cases where CNC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for CNC turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 36 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

CNC broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 12 (best 1 - 100 worst), indicating outstanding price growth. CNC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 44 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CNC's P/B Ratio (1.527) is slightly lower than the industry average of (3.520). P/E Ratio (-6.751) is within average values for comparable stocks, (126.353). Projected Growth (PEG Ratio) (0.754) is also within normal values, averaging (0.786). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.160) is also within normal values, averaging (0.569).

The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 67.69B. The market cap for tickers in the group ranges from 335.99K to 353.79B. UNH holds the highest valuation in this group at 353.79B. The lowest valued company is IHGP at 335.99K.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 2%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was 16%. CVS experienced the highest price growth at 7%, while MOH experienced the biggest fall at 0%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was -43%. For the same stocks of the Industry, the average monthly volume growth was -27% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 43
Price Growth Rating: 37
SMR Rating: 72
Profit Risk Rating: 83
Seasonality Score: -6 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a multi-line healthcare enterprise

Industry ManagedHealthCare

Industry
Managed Health Care
Address
7700 Forsyth Boulevard
Phone
+1 314 725-4477
Employees
61100
Web
https://www.centene.com
Interact to see
Advertisement
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
Micron shares fell -6.28% to $729.40 from Friday's $778.31 close, gapping lower in premarket trading and holding those losses into Monday's regular session. The decline was sector-driven, not company-specific: memory peers SanDisk, SK hynix and Western Digital slid in tandem as last week's Nvidia CEO departure revived doubts over AI data-center spending, financing and memory demand durability.
Dell Technologies (DELL) fell roughly 23.7% over the last 30 days, sliding from a closing price of $451.71 on October 16, 2026, to $344.53 on November 13, 2026. The decline accelerated after the U.S. midterm elections, when investor concerns about potential AI and data-center regulation triggered a sharp sell-off across AI hardware names.
ACHR fell -7.44% in Monday's regular session, sliding from Friday's $4.03 close to $3.73 shortly after 10 a.m. ET — a third consecutive daily decline that pushed shares back toward their November 5 low. No verified news or fundamental catalyst found for today's leg lower; the selling extends the de-rating that followed Q3 results — revenue of just $5.1 million, a net loss widening 111% to $274.6 million, and price-target cuts from Cantor Fitzgerald, Needham and Canaccord.
SKHY fell -6.87% to $122.74 by 10:04 a.m. ET, down $9.05 from Friday's close of $131.79, extending a premarket decline into the regular session. The drop was driven by a sector-wide AI chip selloff ahead of Nvidia's quarterly results on Tuesday, where CEO Jensen Huang's resignation has raised doubts about the durability of data-center spending that underpins high-bandwidth memory demand.
Why Is Centene Corporation (CNC) Stock Up +5.00% Today?